These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1333011)

  • 1. omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists.
    Labaudinière R; Hendel W; Terlain B; Cavy F; Marquis O; Dereu N
    J Med Chem; 1992 Nov; 35(23):4306-14. PubMed ID: 1333011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
    Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
    J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus.
    Gapinski DM; Mallett BE; Froelich LL; Jackson WT
    J Med Chem; 1990 Oct; 33(10):2798-807. PubMed ID: 2170647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel molecules that antagonize leukotriene B4 binding to neutrophils.
    Lin AH; Morris J; Wishka DG; Gorman RR
    Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-[(omega-arylalkyl)thienyl]alkanoic acids: from specific LTA4 hydrolase inhibitors to LTB4 receptor antagonists.
    Labaudinière R; Hilboll G; Leon-Lomeli A; Terlain B; Cavy F; Parnham M; Kuhl P; Dereu N
    J Med Chem; 1992 Aug; 35(17):3170-9. PubMed ID: 1324316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.
    Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT
    J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
    Jackson RH; Morrissey MM; Sills MA; Jarvis MF
    J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.
    Reiter LA; Koch K; Piscopio AD; Showell HJ; Alpert R; Biggers MS; Chambers RJ; Conklyn MJ; Cooper K; Cortina SR; Dibrino JN; Dominy BW; Farrell CA; Hingorani GP; Martinelli GJ; Ramchandani M; Wright KF
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1781-6. PubMed ID: 9873433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
    Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4.
    Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ
    J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
    Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
    Fretland DJ; Widomski D; Tsai BS; Zemaitis JM; Levin S; Djuric SW; Shone RL; Gaginella TS
    J Pharmacol Exp Ther; 1990 Nov; 255(2):572-6. PubMed ID: 2173749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.
    Poudrel JM; Hullot P; Vidal JP; Girard JP; Rossi JC; Muller A; Bonne C; Bezuglov V; Serkov I; Renard P; Pfeiffer B
    J Med Chem; 1999 Dec; 42(26):5289-310. PubMed ID: 10639274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
    Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
    J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.